Supreme Court takes on Pur­due Phar­ma bank­rupt­cy case

The Supreme Court will re­view a case chal­leng­ing Pur­due Phar­ma’s bank­rupt­cy plan, tem­porar­i­ly stay­ing a $6 bil­lion deal that would pro­tect the Sack­ler fam­i­ly from civ­il suits re­lat­ed to the opi­oid epi­dem­ic.

Pur­due filed for bank­rupt­cy in 2019 as law­suits piled up al­leg­ing de­cep­tive mar­ket­ing of its high­ly ad­dic­tive painkiller Oxy­con­tin. The opi­oid epi­dem­ic claimed more than 564,000 lives be­tween 1999 and 2020.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER